I wanted to bring attention to the recent updates from the FDA regarding data management in clinical trials. These guidelines emphasize the importance of data integrity and provide a framework for efficient database management. Implementing these can really enhance our workflow and ensure compliance, particularly as we prepare for our upcoming studies next quarter. Has anyone else started looking into how they’ll adapt to these new standards?